scispace - formally typeset
J

Joëlle Boretto

Researcher at Centre national de la recherche scientifique

Publications -  17
Citations -  959

Joëlle Boretto is an academic researcher from Centre national de la recherche scientifique. The author has contributed to research in topics: Reverse transcriptase & DNA. The author has an hindex of 14, co-authored 17 publications receiving 943 citations. Previous affiliations of Joëlle Boretto include Aix-Marseille University & University of Provence.

Papers
More filters
Journal ArticleDOI

Mechanistic basis for reduced viral and enzymatic fitness of HIV-1 reverse transcriptase containing both K65R and M184V mutations.

TL;DR: The molecular mechanisms by which a virus resistant to lamivudine with the M184V reverse transcriptase mutation shows increased susceptibility to tenofovir and can suppress the effects of the ten ofovir resistance mutation K65R are reported, defining at the molecular level how nucleoside-resistant viruses can be driven to reduced viral fitness.
Journal ArticleDOI

The Molecular Mechanism of Multidrug Resistance by the Q151M Human Immunodeficiency Virus Type 1 Reverse Transcriptase and Its Suppression Using α-Boranophosphate Nucleotide Analogues

TL;DR: The general capacity of such analogues to circumvent multidrug resistance when RT-mediated nucleotide resistance originates from the selective decrease of the catalytic rate constant k pol is highlighted.
Journal ArticleDOI

HIV-1-associated uracil DNA glycosylase activity controls dUTP misincorporation in viral DNA and is essential to the HIV-1 life cycle.

TL;DR: HIV-1 prevents incorporation of dUTP in viral cDNA by UNG2-mediated uracil excision followed by a dNTP-dependent, reverse transcriptase-mediated endonucleolytic cleavage and finally by strand-displacement polymerization.
Journal ArticleDOI

A loss of viral replicative capacity correlates with altered DNA polymerization kinetics by the human immunodeficiency virus reverse transcriptase bearing the K65R and L74V dideoxynucleoside resistance substitutions.

TL;DR: It is shown that recombinant viruses carrying K65R and L74V display the same resistance level to ddI relative to wild type, which explains why the two mutations do not combine in the clinic and might give a mechanism for a decreased viral fitness at the molecular level.
Journal ArticleDOI

General catalytic deficiency of hepatitis C virus RNA polymerase with an S282T mutation and mutually exclusive resistance towards 2'-modified nucleotide analogues.

TL;DR: The determination of the molecular mechanism by which the S282T mutation confers resistance to 2′-modified nucleotide analogues suggests not only that “2′-conformer” analogues target distinct steps in RNA synthesis but also that these analogues have interesting potential in combination therapies.